导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.53% | 738/1050 |
| 近一周 | 0.36% | 235/1104 |
| 近一月 | -6.21% | 874/1103 |
| 近一季 | 7.44% | 113/1092 |
| 近半年 | -2.26% | 522/1070 |
| 近一年 | -17.66% | 865/1018 |
| 近两年 | 33.49% | 654/926 |
| 近三年 | 1.14% | 674/834 |
| 成立以来 | 98.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.73% 755/1070 |
-3.93% 769/1101 |
- - |
- - |
| 2025 | 29.99% 473/1065 |
11.28% 120/1014 |
10.08% 100/1038 |
19.08% 632/1050 |
-10.89% 910/1065 |
| 2024 | -18.87% 894/1011 |
-9.15% 748/960 |
-9.23% 838/983 |
7.81% 786/991 |
-8.74% 857/1011 |
| 2023 | -7.08% 256/952 |
5.89% 261/880 |
-1.57% 275/895 |
-11.12% 632/915 |
0.31% 109/952 |
| 2022 | -19.44% 306/867 |
-15.73% 293/773 |
-2.32% 730/806 |
-8.18% 151/845 |
6.58% 145/867 |
| 2021 | -6.21% 435/740 |
-3.55% 284/580 |
14.51% 246/659 |
-10.04% 506/704 |
-5.60% 608/740 |
| 2020 | 84.26% 79/554 |
12.50% 33/419 |
40.27% 24/466 |
3.27% 385/517 |
13.07% 248/554 |
| 2019 | 56.20% 100/410 |
23.45% 815/1149 |
1.84% 178/1231 |
17.83% 24/390 |
5.44% 335/410 |
| 2018 | -19.93% 78/349 |
- - |
- - |
- - |
-17.19% 958/1080 |
| 2017 | -6.28% 188/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.06% 86/205 |
- - |
- - |
- - |
- - |
| 2015 | 59.34% 12/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 鹏华医疗保健股票 VS. 东吴新产业精选股票A(580008) |